Literature DB >> 22691014

Physical activity as a protective factor in relapse following smoking cessation in participants with a depressive disorder.

Paquito Bernard1, Gregory Ninot, Sebastien Guillaume, Guillaume Fond, Philippe Courtet, Marie Christine Picot, Xavier Quantin.   

Abstract

The factors predicting smoking abstinence in depressive smokers, and the role of physical activity in precessation, were investigated. One hundred thirty-three smokers with current major depressive disorders (score ≥10 on the Depression subscale of Hospital Anxiety and Depression Scale) were recruited from a large prospective cohort of smokers (n = 1,119). Over a maximum period of 3 years, regression modeling, adjusted for potential confounders, showed that physical activity was associated with relapse (relapse rate = 0.54, 95% confidence interval = 0.34-0.85, p = .008). Also, antidepressants, anxiolytics, level of education, and number of attempts to quit were associated with relapse. The protective role of physical activity on relapse rate could be a modifiable factor in smoking cessation for smokers with depressive disorders.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691014     DOI: 10.1111/j.1521-0391.2012.00242.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  3 in total

1.  Association between Low-Dose Computed Tomography Results and 1-Year Smoking Cessation in a Residential Smoking Cessation Program.

Authors:  Da-Som Shin; Hye-Mi Noh; Hong Ji Song; Kyung Hee Park; Young-Gyun Seo; Yu-Jin Paek
Journal:  Int J Environ Res Public Health       Date:  2022-05-01       Impact factor: 4.614

2.  The Role of Physical Activity Enjoyment on the Acute Mood Experience of Exercise among Smokers with Elevated Depressive Symptoms.

Authors:  Ana M Abrantes; Samantha G Farris; Sarah L Garnaat; Alexia Minto; Richard A Brown; Lawrence H Price; Lisa A Uebelacker
Journal:  Ment Health Phys Act       Date:  2017-02-10

Review 3.  Lifestyle medicine for depression.

Authors:  Jerome Sarris; Adrienne O'Neil; Carolyn E Coulson; Isaac Schweitzer; Michael Berk
Journal:  BMC Psychiatry       Date:  2014-04-10       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.